PRGO (Perrigo Company PLC) Net Profit

Corporate emblem and logo of perrigo.com (PRGO)

Perrigo Company plc (PRGO) is actively implementing robotic filling and packaging control lines. However, global trade barriers and logistical complexities are compressing operational margins. Stable demand for affordable generics and pricing power support the business, while the company's bottom line demonstrates financial resilience, and the value of -1.74 reflects this status at the current stage.

PRGO (Perrigo) Company Net Income history from 07/04/2022 to 10/29/2026

Financial and market metric breakdowns for Perrigo (PRGO)

- price and consensus price forecast:
Stock Quotes Perrigo Corp|PRGO - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Perrigo Corp|PRGO - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Perrigo|PRGO - Company Book Value|Market-to-Book Ratio perrigo.com|PRGO - Cumulative Company Assets
- debt and solvency information:
Aggregate Debt to Capital Perrigo Company plc|PRGO - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Perrigo Company PLC|PRGO - Company Aggregate Debts|Debts to Book Value Perrigo Corp|PRGO - Company Long-Term Debt|Company Short-Term Loans and Borrowings Perrigo|Critical Liquidity Ratio perrigo.com
- net income and valuation multiples indicators:
PRGO - Net Profit
Fundamental valuation:PRGO Perrigo Corp
Flagship merchandise of Perrigo Company PLC

Perrigo Company plc (PRGO) profit reflects the net financial result after deducting all operating and tax expenses, serving as a key indicator of shareholder capital management efficiency. The consolidated profit dynamics of Perrigo Company plc (PRGO) confirm the returns on R&D and production automation investments, transforming technological leadership into actual cash flow and ensuring sustainable business value.

Main competitors

Net Income Haleon Corp|KVUE (Kenvue Inc.) - Net Profit|Net Profit veronapharma.com|Net Income MENS (Jyong Biotech)|LGND (Ligand Pharmaceuticals Incorporated) - Final Profit|Company Net Income Amneal Pharmaceuticals Inc AMRX|Alvotech Biopharmaceuticals (ALVO) - Company Net Income|LQDA: Net Income|glpg.com - Profit After Payment of Taxes|ANIP: Net Profit|MannKind Corp - Final Profit|AMPH (Amphastar) - Net Profit|Company Net Income Pacira Corp PCRX|Company Net Income ARS Pharmaceuticals (SPRY)|TBPH (theravance.com) - Final Profit|Company Net Income Aquestive Therapeutics, Inc. AQST|SCPH (scPharmaceuticals, Inc.) - Profit After Tax|Tectonic - Net Profit|Company Net Income Tonix Pharmaceuticals Holding|sxtchina.com (SXTC) - Company Net Income|Eupraxia Pharmaceuticals Inc. - Final Profit|Company Net Income BioHarvest Sciences Inc.|EXOZ: Final Profit|Net Profit ORMP|Net Financial Result enterabio.com|Net Profit HYFT (MindWalk Holdings)|Annual Net Income abvcpharma.com|CPIX - Company Net Income|Company Net Income Quantum BioPharma Ltd.|FGEN (FibroGen Corp) - Net Income|Telomir Pharmaceuticals Corp - Final Profit|RANI (Rani Therapeutics Holdings) - Net Profit|Net Income Synergy CHC Corporation (SNYR)|Company Net Income Rallybio Corporation (RLYB)|LEXX - Company Net Income|Company Net Income Pulmatrix Corp PULM|PTHL - Net Income|APM - Company Net Income|Profit After Tax LYRA|IBO: Net Profit|TNF Pharmaceuticals, Inc. (TNFA) - Net Profit|Company Net Income cbdMD Inc.|Company Profit PRFX (PainReform Corp)|Net Income CYTO (Altamira Therapeutics)|LIPO - Company Net Income|OptiNose - Net Income|Final Profit PIRS|PROC - Company Net Income|Profit After Tax PTPI|Qilian International (QLI) - Company Net Income|SLRN (acelyrin.com) - Company Net Income|TFFP (TFF Pharmaceuticals, Inc.) - Net Profit